Foxp3
+ regulatory T cell (Treg)-based immunotherapy holds promise for autoimmune diseases. However, this effort has been hampered by major caveats, including the low frequency of autoantigen-specific Foxp3 + Tregs and lack of understanding of their molecular and cellular targets, in an unmanipulated wild-type (WT) immune repertoire. In this study, we demonstrate that infusion of myelin in WT mice results in the de novo induction of myelin-specific Foxp3 + Tregs in WT mice and amelioration of experimental autoimmune encephalomyelitis. Myelin-specific Foxp3 + Tregs exerted their effect both by diminishing Ag-bearing inflammatory dendritic cell (iDC) recruitment to lymph nodes and by impairing their function. Transcriptome analysis of ex vivoisolated Treg-exposed iDCs showed significant enrichment of transcripts involved in functional properties of iDCs, including chemotaxis-related genes. To this end, CCR7 expression by iDCs was significantly downregulated in tolerant mice and this was tightly regulated by the presence of IL-10. Collectively, our data demonstrate a novel model for deciphering the Ag-specific Foxp3 R egulatory T cells (Tregs) play an indispensable role in the maintenance of the immune homeostasis and the re-establishment of tolerance based on equivocal data both in mice and humans (1, 2) . To this end, Treg-deficient mice develop lethal multiorgan autoimmunity, whereas in humans impaired Treg development leads to life-threatening autoimmune diseases (3) (4) (5) . Although major effort has been placed in exploiting Tregs for therapeutic intervention in autoimmune diseases, in transplant rejection and allergy, this has been hampered by numerous caveats and impediments. First, emerging data suggest that the efficacy of Treg-mediated suppression is critically depended on Ag specificity. Because Ag-specific Tregs are infrequent in an unmanipulated repertoire (6) , it is essential to devise protocols able to enhance their frequency either in vitro and/ or in vivo. Second, growing knowledge supports the existence of diverse Treg subtypes with immunosuppressive potential, including natural Foxp3 + Tregs, adaptive Foxp3 + Tregs, and Tr1 regulatory cells (7, 8) . The relative contribution of these Treg subsets in the maintenance of homeostasis and tolerance as well as the stability of their phenotype and function in vivo are ill defined (9) . Finally, the molecular and cellular targets of the Treg-mediated suppression in an intact immune system remain elusive.
Accumulating data during the last decade have described multiple and diverse molecules and mechanisms to be involved in Foxp3 + Treg-mediated suppression. These include 1) direct cellto-cell contact-dependent mechanisms; to this end, expression of CTLA-4, gallectin-1, LAG-3, neuropilin1, and granzyme B by Tregs have all been shown to affect the function and/or survival of APCs and effector T cells; 2) secretion of immunosuppressive soluble mediators by Tregs, such as IL-10, TGF-b, and IL-35, which have been implicated in Treg suppressive activity; and 3) deprivation of IL-2, which may directly suppress effector T cell proliferation and function (1, 2, 10, 11) . Although this knowledge has put the field a step forward, major questions regarding the relative contributions of the aforementioned mechanisms in Treg-mediated suppression in vivo as well as the specific cellular targets of Tregs remain unanswered. Importantly, experimental observations on Treg-mediated suppression have severe limitations, as they have been generated mainly using Tregs from either skewed TCR transgenic repertoires or gene-disrupted animals or via Ab-mediated elimination. Whether these data can be extrapolated to wild-type (WT) animals with an unmanipulated immune cell repertoire remains to be seen. Deciphering the relevant modes and targets of Treg-mediated suppression in a given inflammatory milieu in vivo in a WT immune cell repertoire would greatly advance the efforts toward the design of customized Ag-specific Treg-mediated immunotherapies and ultimately the re-establishment of tolerance.
In this study, we demonstrate that infusion of a myelin Ag in unmanipulated WT mice results in de novo generation of myelin-specific Foxp3 + Tregs and concomitant induction of selftolerance. Furthermore, we identify Ag-bearing inflammatory DCs (iDCs) as the cellular target of the generated myelinspecific Foxp3 + Tregs, because the latter reduce their accumulation in the draining lymph nodes (dLNs) of tolerant mice and impair their function. Finally, transcriptomic analysis of Tregexposed iDCs revealed attenuated CCR7-mediated signaling that was dependent on the presence of IL-10. Overall, our data describe a novel model for induction of self-antigen-specific Foxp3 + Tregs in WT animals and shed light on the mechanism of Ag-specific Treg-mediated suppression of autoimmune responses in an unmanipulated immune repertoire.
Materials and Methods
Mice C57BL/6, BALB/c, and Il10 2/2 mice (C57BL/6 background), purchased from The Jackson Laboratory, depletion of Treg (DEREG) mice (C57BL/6 background), provided by Dr. Tim Sparwasser (Institute of Infection Immunology, TWINCORE, Hannover, Germany), Foxp3gfp.KI mice (C57BL/6 background), provided by Dr. Alexander Rudensky (Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY), and 2D2 TCR transgenic mice, provided by Dr. Lesley Probert (Hellenic Pasteur Institute, Athens, Greece), were used in this study. All procedures were in accordance with institutional guidelines and were approved by the Greek Federal Veterinary Office. All mice used in the experiments were 8-to 10-wk-old females.
In vivo protocols and experimental autoimmune encephalomyelitis induction
For peptide delivery, mice were implanted s.c. with osmotic micropumps (Alzet 1002; Durect) infusing 10 mg per day of myelin oligodendrocyte glycoprotein (MOG) peptide (Genemed Synthesis) for 14 d. Mice were subsequently immunized s.c. at the base of the tail with 100 mg MOG (Genemed Synthesis) or OVA (endograde V, Sigma-Aldrich) emulsified (1:1) in CFA (Sigma-Aldrich). Analysis was performed 12 d after immunization.
For experimental autoimmune encephalomyelitis (EAE) induction, mice were immunized s.c. at the base of the tail with 100 mg MOG in CFA. Mice also received i.p. injections of 200 ng pertussis toxin (SigmaAldrich) at the time of immunization and 48 h later. Mice were monitored daily for clinical signs of disease as described (12) 
Flow cytometry and cell sorting
Single-cell suspensions were prepared from tissues and live cells (7-aminoactinomycin D [7AAD], BD Biosciences) were stained with conjugated Abs to CD11c (N418), CD11b (M1/70), Gr-1 (RB6-8C5), I-A b (AF6-120.1), CD3e (145-2C11), CD19 (1D3), CD4 (RM4-5), CD8a (53-6.7), Va3.2 (RR 3-16), Vb11 (KT11), CD44 (IM7), CTLA-4 (CD152, UC10-4B9), LFA-1 (CD11a, M17/4), LAG-3 (CD223, C9B7W), GITR (CD357, DTA-1), CD25 (3C7), Helios (22F6), PD-L1 (10F.962), PD-L2 (DY25), CD80 (16-10A1), CD86 (GL-1), CD40 (3/23) (BioLegend), and CCR7 (CD197, EBI-1) (eBioscience). Foxp3 staining was performed using the Foxp3 (FJK-16s) staining set (eBioscience). For tetramer staining, 2 3 10 6 cells were incubated for 5 min with 10% mouse and rat sera (Jackson ImmunoResearch Laboratories) followed by 45 min staining with 10 mg/ml I-A b /MOG 38-49 tetramer or I-A b /hCLIP control tetramer (obtained from the National Institutes of Health Tetramer Facility) at room temperature. mAbs and viability dyes were added thereafter for 20 min on ice. For isolation of iDCs, dLNs and spleens were digested with collagenase D (2 mg/ml; Roche) for 30 min at 37˚C. For the purification of total DCs, single-cell suspensions were incubated with Pan DC MicroBeads (Miltenyi Biotec) and then positively selected on a magnetic field according to the manufacturer's instructions (Miltenyi Biotec). For the purification of iDCs, positively selected DCs were stained with mAbs against CD11c, CD11b, and Gr-1. CD11c + CD11b + Gr-1 + cells were sorted on a high-speed MoFlo (Dako). Cell purity was ∼85-95%.
For intracellular IL-10 staining, cells were isolated as described and stimulated in culture medium containing PMA (50 ng/ml, SigmaAldrich) and ionomycin (2 mg/ml, Sigma-Aldrich) for 4 h at 37˚C. Brefeldin A (10 mg/ml, eBioscience) was added for 2 h. Following staining of surface markers cells were fixed with paraformaldehyde and permeabilized with 10% saponin buffer (Sigma-Aldrich). Cells were then incubated with IL-10 mAb (JES5-16E3, BioLegend). Cells were acquired on a FACSCalibur (BD Biosciences) and analyzed using FlowJo software (Tree Star).
For analysis of Ag uptake by DC subsets, mice were s.c. immunized with 100 mg OVA-Alexa Fluor 488 (Molecular Probes) in CFA. Then, 3.5 d later dLN cells (dLNCs) were isolated and stained for various DC subsets. 
Adoptive transfer experiments

Histological analysis and immunofluorescence
To assess CNS inflammation, mice were perfused with 4% paraformaldehyde. The spinal cords were dissected and fixed, followed by 30% sucrose. Fixed tissues were then frozen with OCT. Five-micrometer sections of the spinal cord were stained with H&E and analyzed in a blinded fashion.
For immunofluorescence staining, tissue was permeabilized by immersing the frozen sections in acetone for 10 min at 220˚C. Sections were rinsed in PBS and blocked with 0.5% Triton X-100 solution for 60 min. Sections were then incubated overnight with rabbit anti-GFP Ab (1:500, Minotech Technologies). The next day sections were incubated for 1 h with anti-rabbit CF 488A IgG (1:800, Biotium). DAPI (300 nM, SigmaAldrich) fluorescent dye was used for nuclear staining.
T cell proliferation assays and cytokine assessment
Inguinal dLNs were harvested 9 d after immunization and 4 3 10 5 cells were cultured in the presence or absence of MOG or OVA (30 mg/ml) for 72 h. Cells were then pulsed with 1 mCi
3
[H]thymidine (TRK120; Amersham Biosciences) for 18 h, and incorporated radioactivity was measured using a Beckman beta counter. Results are expressed as stimulation index defined as cpm in the presence of Ag/cpm in the absence of Ag. Cytokines were assessed in culture supernatants, collected after 48 h of stimulation. In other experiments sorted iDCs were stimulated with or without LPS (1 mg/ml; Sigma-Aldrich). Cytokines were assessed in supernatants, collected 18-20 h later. Pulsed iDCs (2 3 10 4 ) were then cultured in the presence of dLNCs (4 3 10 5 ) as responders, isolated from mice, 9 d following MOG /CFA immunization in the presence of MOG peptide (30 mg/ml). Cytokines were assessed in culture supernatants 48 h later. In other experiments, 4 3 10 4 iDCs (isolated as described above) were cultured in a 1:1 ratio with CFSE-labeled (1 mM) dLNCs isolated from BALB/c mice in a MLR. In some experiments dLNs were dissected and homogenized with PBS containing protease inhibitors mixture (Roche). Detection of IL-2, IFN-g (BD OptEIA, BD Biosciences), and CXCL1 (KC), TNF-a, IL-10, and IL-17 (DuoSet, R&D Systems) was performed by ELISA following the manufacturers' recommendations. In other experiments, inguinal LNs were dissected and homogenized with PBS containing protease inhibitors mixture (Roche). Detection of CCL19 and CCL21 (DuoSet, R&D Systems) in supernatants of dLN homogenates was performed by ELISA. 
In vitro suppression assay
GeneChip hybridization and data analysis
Total RNA from iDCs isolated from spleen and dLNs of tolerized/MOG immunized or MOG -immunized mice 9 d following immunization was prepared with a Qiagen RNeasy mini kit. All experiments were repeated three times with individually sorted cells purified to .96% homogeneity. Hybridization on Affymetrix MG430 2.0 GeneChip arrays was performed at the Ramin gene array facility, and high-performance chip data analyses with the BioRetis database as well as hierarchical clustering were performed in the Bioinformatics Department of the German Rheumatism Research Center (Berlin, Germany) and validated as described (13) . All chip data were uploaded to Gene Expression Omnibus (http:// www.ncbi.nlm.nih.gov/geo, accession no. GSE47210) and are publicly available.
Quantitative PCR analysis iDCs were isolated as described above, followed by reverse transcription with a ThermoScript reverse transcriptase kit (Invitrogen). Transcripts were quantified by incorporation of Platinum SYBR Green (Bio-Rad Laboratories) with a StepOnePlus real-time PCR system (Applied Biosystems), and expression was calculated by the change-in-threshold method (DDC T ) with Hprt mRNA (encoding hypoxanthine phosphoribosyltransferase 1). Specific primers were as follows: Hprt, forward, 59-GTGAAACTG-GAAAAGCCAAA-39, reverse, 59-GGACGCAGCAACTGACAT-39; Ccr7, forward, 59-GCTCCAGGCACGCAACTTT-39, reverse, 59-GACTACCA-CCACGGCAATGA-39.
Western blot analysis
Whole-cell lysates (40 mg protein) were subjected to SDS-PAGE electrophoresis on 12% gels and then transferred to an Immobilon-P sq membrane (Millipore). Membranes were blocked with 5% skimmed milk, 1% BSA, or 5% BSA in TBST and then incubated with anti-phospho-PI3K p85 (Tyr 
Statistical analysis
Statistical analyses were performed using a Student t test. Data are presented as means 6 SEM. Differences were considered statistically significant at p , 0.05. All data were analyzed using GraphPad Prism v5 software.
Results
Subimmunogenic delivery of MOG 
peptide in WT animals ameliorates EAE
The efficacy of Tregs in exerting their function is critically dependent on their Ag specificity (14, 15) ; however, Ag-specific Tregs are rare in an intact T cell repertoire. Others and we have previously demonstrated that subimmunogenic delivery of a foreign TCR agonist in WT animals leads to Ag-specific tolerance (16) (17) (18) . To examine whether this method is suited for induction of self-tolerance, mice were infused with the self-peptide MOG and monitored for EAE development. Notably, MOG -infused/ MOG -immunized mice experienced significantly decreased severity and disease onset (Fig. 1A) and reduced inflammatory lesions in the spinal cords (Fig. 1B) immunized mice showed a defective induction of IL-2, IFN-g, and IL-17, accompanied by markedly reduced cell proliferation compared with control-immunized dLNCs (Fig. 1C) . To address whether MOG infusion tolerated specifically the selfreactive T cells, MOG -infused mice were immunized with OVA in CFA and dLNCs were restimulated in vitro with MOG or OVA. Based on the production of IFN-g and IL-17, the immunogenicity of OVA was not affected (Fig. 1D) 
CD4
+ T cells from the respective groups were unable to inhibit T cell proliferation (Supplemental Fig. 2) . Overall, our data provide evidence for the induction of MOG these cells in the amelioration of EAE. To explore this hypothesis, we performed the tolerization protocol in DEREG mice (Fig. 3A (Fig. 3B) . Additionally, robust secretion of IFN-g and IL-17 as well as heightened T cell proliferation were observed in recall in vitro assays of dLNCs isolated from tolerized/Foxp3 + Treg-depleted/MOG 35-55 -immunized DEREG mice as compared with cells obtained from tolerized/MOG 35-55 -immunized mice (Fig. 3C) . Collectively, our data demonstrate the operation of dominant tolerance executed by myelin-specific Foxp3 + Tregs in tolerized mice. Overall, our model provides a novel tool for delineation of mechanisms involved in Treg-mediated tolerance in an unmanipulated immune system. DCs expressing such phenotype have been characterized as iDCs (20) (21) (22) with a potent ability to augment T cell responses. Characterization of the function of iDCs in our setting demonstrated that iDCs isolated from MOG -immunized dLNs secreted vast amounts of proinflammatory cytokines such as CXCL1 and TNF-a (Fig. 5A) , and they significantly enhanced MOG -specific Th1 and Th17 responses in vitro (Fig. 5B) , thus confirming their inflammatory properties. Importantly, immunization of mice with OVA-Alexa Fluor 488/CFA demonstrated that Ag was mostly displayed by iDCs in the dLNs, whereas other CD11c-expressing cells only slightly contributed in Ag transport to dLNs (Fig. 5C) (Fig. 5D) , whereas expression of CD80, CD40, PD-L1, and PD-L2 was not affected (Fig. 5D) To gain insight into the mechanisms underlying Treg-mediated modulation of iDC function, we determined the gene expression pattern of iDCs from tolerized and control-immunized mice using Affymetrix expression microarrays. Surprisingly, 5155 differentially regulated transcripts were identified in iDCs from tolerized mice (data not shown). Hierarchical clustering, using Genes@Work with Pearson correlation and center of mass, pointed to an enrichment of genes encoding molecules involved in chemotaxis (for example Ccr7) (Fig. 6A) , suggesting that tolerance induction through MOG -specific Foxp3 + Tregs can regulate pathways critical for iDC migration to dLNs. To validate the microarray results, we performed quantitative real-time PCR for Ccr7. Ccr7 expression by iDCs isolated from tolerized/MOG 35-55 -immunized animals was found significantly reduced (Fig. 6B) . Trafficking of DCs in dLNs is tightly regulated through interactions of LN stroma-derived CCL19 and CCL21 chemokines and CCR7 expressed by DCs (22, 23) . To this end, we assessed whether MOG infusion affected the secretion of these two chemokines. No significant differences were observed for CCL19, whereas CCL21 levels were increased in tolerized/MOG 35-55 -immunized dLN homogenates (Fig. 6C) . Our data indicate that MOG -specific Foxp3 + Tregs impair the accumulation of iDCs in the dLNs via downregulation of CCR7 expression.
Impaired migration and function of Ag-bearing inflammatory
Inhibition of IL-10 signaling in tolerized/MOG 35-55 -immunized animals restores iDC trafficking to the dLNs
Immunomodulatory cytokines such as IL-10 have been linked to Treg suppressive function (24) (25) (26) . To examine whether the elevated secretion of IL-10 by Tregs was involved in the decreased accumulation of iDCs to dLNs of tolerized mice, we administered an IL-10R neutralizing Ab following completion of MOG infusion (Fig. 7A) . Neutralization of IL-10R signaling resulted in a 3-fold induction in the proportion of iDCs in dLNs of tolerized/ MOG -immunized/IL-10R-treated mice compared with the tolerized/MOG 35-55 -immunized group (Fig. 7B) . Interestingly, blocking of IL-10R signaling in tolerized/MOG -immunized mice resulted in the upregulation of the expression of Ccr7 (Fig. 7C) (Fig. 7D ) that was accompanied by enhanced expression of CCR7 on iDCs (Fig. 7E) , confirming thus that IL-10 affects the recruitment of iDCs in the dLNs though regulation of CCR7 expression. Finally, to gain insight into the molecular signaling regulating the IL-10-mediated recruitment of iDCs, we studied the expression of signaling molecules implicated in controlling CCR7-mediated chemotaxis. Generally, chemokine receptors mediate signaling via MAPKs such as JNK and p38. These molecules are important regulators of chemotaxis and random motility in a variety of cells (27) (28) (29) . Chemokine receptors may also activate PI3K and the downstream effector target protein kinase B (Akt), which plays a central role in regulation of the chemotactic response in leukocytes and other cells (30, 31) . We analyzed whether deficiency of IL-10 induced the activation of JNK/p38 or PI3K/Akt axis in DCs. For this, DCs were isolated from dLNs and spleen of MOG 35-55 -immunized Il10 2/2 or WT littermates. The cells were lysed and the lysates were analyzed by Western blotting using Abs specific for the phosphorylated/active forms of the proteins mentioned above. Although we were not able to detect any differences in the phosphorylation pattern of MAPKs, JNK, and p38 (Fig. 7D) , DCs isolated from Il10 2/2 /MOG 35-55 -immunized mice had increased phosphorylation of p85, the regulatory subunit of PI3K, as well as increased phosphorylation of Akt (Fig. 7D ) compared with DCs isolated from Il10 +/+ /MOG 35-55 -immunized littermates. These data suggest that the PI3K/Akt signaling pathway is involved in the IL-10-mediated inhibition of chemotaxis in DCs.
Discussion
Foxp3-expressing Tregs play a pivotal role in the maintenance of self-tolerance, and thus methods seeking their generation and expansion are of great importance in the field of autoimmunity, where self-tolerance is disturbed. In this study, we demonstrate the de novo induction of autoantigen-specific Foxp3 + Tregs in an unmanipulated immune repertoire and the concomitant induction of self-tolerance, and we provide new insights into the molecular and cellular bases that underlie Foxp3 + Treg-mediated suppression of autoimmune responses. To this end, we demonstrate that myelin-specific Foxp3 + Tregs 1) restrain the accumulation of Agbearing iDCs, which are required for the priming of encephalitogenic responses, in the dLNs, and 2) target the CCR7-dependent migration of iDCs in an IL-10-depedent manner.
Induction and/or expansion of Ag-specific Foxp3 + Tregs has been documented in a plethora of studies. To this end, oral administration or i.v. injection of myelin peptides induce tolerance in EAE via induction of T cell clonal anergy (32, 33) or through autoreactive T cell deletion (34), respectively. Additionally, transdermal administration of myelin peptides successfully inhibited EAE in TCR transgenic animals (35, 36) . Finally, expression of Ag by tissue-resident cells or delivery of Ag by either targeting the DCs or using infusion protocols resulted in generation of Ag-specific Tregs (18, (37) (38) (39) . However, to our knowledge, our study for the first time demonstrates direct evidence for the operation of dominant tolerance executed by myelin-specific Foxp3 + Tregs induced in unmanipulated mice and subsequent amelioration of EAE. However, whether these methods could be http://www.jimmunol.org/ adopted to generate self-antigen-specific Foxp3 + Tregs in a WT immune repertoire remains unknown. Importantly, generation of myelin-specific Foxp3 + Tregs did not induce a generalized immunosuppression, because immune responses against foreign Ag were not compromised. In line with this result, Kasagi et al. (40) recently demonstrated that radiation-triggered apoptosis results in autoantigen-specific Tregs that treat ongoing autoimmunity without affecting immune responses to bacterial Ags.
Our observations raise important questions regarding the relative contribution of other Treg subsets in amelioration of EAE and establishment of self-tolerance. Notably, in our model the disease induced in tolerized mice upon elimination of myelin-specific Foxp3 + Tregs appeared to be less aggressive and less severe compared with control-immunized animals, suggesting the operation of additional mechanisms of tolerance. Additionally, the increased frequency of the IL-10-producing Foxp3-GFP 2 T cell population in tolerant mice suggests a possible role of peripherally induced Tr1-like suppressor cells (41, 42) in the amelioration of disease. Although, whether IL-10 + Foxp3 2 CD4 + T cells in tolerized mice are indeed suppressive and involved in the reestablishment of self-tolerance has not been examined; however, recent evidence demonstrated that both natural Foxp3 + and induced Tregs are required for operation of tolerance (43) . The mechanisms underlying the induction of IL-10-producing Tr1-like cells remain largely unknown. It is possible that myelin peptide uptake by immature or semimature APCs could instruct the induction of myelin-specific Tr1 cells in the periphery of infused mice that act in concert with thymus-derived myelin-specific Foxp3 + Tregs toward the re-establishment of self-tolerance. In support of this idea, it has been demonstrated that the maturation status of DCs could direct the induction of IL-10-producing Tregs both in vivo and in vitro (44, 45) . Regardless of the relative contribution of distinct cell-intrinsic mechanisms of tolerance or inducible Treg subsets in the re-establishment of self-tolerance in our model, our results clearly demonstrate that myelin-specific Foxp3 + Tregs possess a central role in the re-establishment of self-tolerance by suppressing the migration of Ag-bearing iDCs in the dLNs of tolerant mice.
The Treg-mediated suppression of DC activation and function has been extensively proposed based on in vitro (46) (47) (48) and in vivo studies (49, 50) . However, the DC lineage is heterogeneous and the precise subset that is targeted by Tregs is unknown. Furthermore, different DC subsets might be involved in tolerance induction in different inflammatory settings or at different inter- faces. Our data reveal that self-antigen-specific Foxp3 + Tregs diminish the accumulation of CD11c + CD11b hi Gr-1 + iDCs that carry Ag to the dLNs. iDCs secrete significant amounts of proinflammatory cytokines and endow MOG -specific Th1 and Th17 responses, confirming their robust inflammatory properties (21) . Furthermore, iDCs are absent from the dLNs during the steady-state and they gradually appear upon encountering the inflammatory insult. Because migration of Ag-bearing DCs to peripheral lymphoid compartments plays an essential role in the initiation of adaptive immune responses (51, 52) , we propose that in our model myelin-specific Foxp3 + Tregs exert their function at least by affecting the trafficking of iDCs. Additionally, iDC levels were restored in dLNs of tolerized animals upon Foxp3 + Treg depletion. Finally, DNA microarrays of iDCs isolated from the dLNs of tolerized mice demonstrated a significant enrichment in genes closely linked to cell migration. Specifically, our results demonstrated that the expression of ccr7, required for DC mobilization to LNs (53), was significantly downregulated in iDCs from tolerant mice compared with iDCs from control animals.
How Foxp3 + Tregs impair the iDC trafficking at a molecular level is not known. Our results demonstrate that in vivo neutralization of IL-10 signaling in tolerized animals is essential for restoring the iDC levels to dLNs, and this was accompanied by increased levels of CCR7 expression by iDCs. CCR7-mediated migration of DCs to dLNs is pivotal for the initiation of an immune response (23, 54) . Both CCL19 and CCL21, which are known to orchestrate DC migration to LNs (55), were not reduced in LN homogenates of tolerant mice, suggesting that the impaired iDC migration to LNs could not be attributed to differences in the expression of CCR7 ligands and points toward differences in the molecular pathways downstream of CCR7. CCR7 stimulation leads to phospholipase C activation followed by diacylglycerol-mediated activation of protein kinase C and intracellular calcium release (56) . Following this, a variety of signaling molecules have been implicated in the CCR7-mediated chemotaxis of DCs as well as their migratory speed. To this end, activation of PI3K and the downstream target protein Akt have been shown to coordinate chemotactic responses of inflammatory cells (30) . Additionally, MAPKs have also been implicated in the regulation of chemotaxis as well as in cell motility (57) . Whether IL-10 affects any of these pathways and thus DC chemotaxis remains elusive. Our results highlight that IL-10 regulates the PI3K/Akt pathway in iDCs during MOG /CFA immunization, suggesting that this pathway might be crucial for the coordinated chemotaxis and/or migratory speed of iDCs in our model. Taking into account the several DC subtypes, it is possible that different signaling events under specific inflammatory environments could operate to facilitate the DC migration and positioning into the dLNs.
In summary, our results suggest a model for the de novo generation of self-antigen-specific Foxp3 + Tregs in unmanipulated mice and provide evidence for the Ag-bearing iDCs as a target of the Foxp3 + Treg-mediated induction of self-tolerance. Protocols aiming at the induction and/or expansion of self-antigen-specific Foxp3 + Tregs provide invaluable knowledge toward the design of cell-based therapies in autoimmune diseases that could confer specificity avoiding a pan-immunosuppression. Importantly, these findings have the potential of extending beyond the autoimmunity field to allergic responses, graft-versus-host disease, and solid organ rejections during transplantation regimens whereby disturbed tolerance is a common denominator.
